Screener › Biotech Small Cap Stocks
Biotech Small Cap Stocks
Small and micro cap biotech stocks under $5B market cap — high-risk, high-reward pipeline plays in gene therapy, oncology, rare diseases, and precision medicine.
| Ticker | Société | Cours | Capitalisation | Potentiel | Pos. 52sem. | Smart Money |
|---|---|---|---|---|---|---|
| DOCS | Doximity, Inc. | $27.40 +32.62% | $4.93B | -9.2% | 17.3% | — |
| EWTX | Edgewise Therapeutics | $43.52 -2.03% | $4.68B | 14.7% | 86.5% | — |
| WAY | Waystar Holding Corp. | $24.23 +3.68% | $4.65B | 37.5% | 28.8% | — |
| ICUI | ICU Medical, Inc. | $184.56 +10.93% | $4.61B | -1.1% | 90.3% | — |
| INDV | Indivior Pharmaceuticals, Inc. | $38.82 +0.39% | $4.58B | 26.2% | 81% | — |
| FOLD | Amicus Therapeutics | $14.49 +0% | $4.55B | 0.1% | 99.9% | — |
| NVST | Envista Holdings | $28.14 +2.78% | $4.52B | 8.1% | 80.4% | — |
| CON | Concentra Group Holdings Parent | $34.10 +11.66% | $4.36B | -0.3% | 93.7% | — |
| ITGR | Integer Holdings Corporation | $125.25 -0.65% | $4.25B | -6.3% | 99.5% | — |
| IRTC | iRhythm Technologies | $127.84 -0.22% | $4.2B | 38.5% | 24.3% | — |
| LIVN | LivaNova PLC | $76.22 +0.58% | $4.2B | 17.3% | 75.3% | — |
| LFST | LifeStance Health Group, Inc. | $10.84 +1.69% | $4.14B | 16.2% | 88.3% | — |
| VKTX | Viking Therapeutics | $34.26 +2.88% | $4B | 171.2% | 56% | — |
| HAE | Haemonetics Corporation | $87.83 +3.31% | $4B | 3.8% | 98.2% | — |
| DNLI | Denali Therapeutics | $24.83 +0.4% | $3.94B | 35.7% | 83.2% | — |
| CPRX | Catalyst Pharmaceuticals, Inc. | $31.49 +0% | $3.85B | 0.6% | 92.1% | — |
| VCYT | Veracyte, Inc. | $47.22 +2.32% | $3.8B | 22.4% | 60.1% | — |
| RCUS | Arcus Biosciences, Inc. | $28.64 +1.09% | $3.65B | 32.7% | 86.5% | — |
| OGN | Organon & Co. | $13.61 +0.41% | $3.57B | -17.3% | 99.9% | — |
| OPCH | Option Care Health, Inc. | $23.79 +0.68% | $3.56B | 20.2% | 30.8% | — |
| FIE.DE | Fielmann | $42.10 +0.36% | $3.53B | 39.3% | 18.4% | — |
| SFZN.SW | Siegfried Holding | $79.65 +2.25% | $3.49B | 24.8% | 39.9% | — |
| NHC | National HealthCare Corporation | $212.78 -3.04% | $3.32B | — | 85.3% | — |
| CLDX | Celldex Therapeutics | $41.71 +0.36% | $3.27B | 39.2% | 94.8% | — |
| ARQT | Arcutis Biotherapeutics | $25.29 -4.31% | $3.18B | 44.8% | 64.1% | — |
| ALHC | Alignment Healthcare | $14.37 +7.4% | $2.98B | 67.6% | 10.9% | — |
| ACHC | Acadia Healthcare Company, Inc. | $31.53 +2.64% | $2.94B | 5.9% | 82.4% | — |
| TMDX | TransMedics Group | $83.89 +4.59% | $2.9B | 17.8% | 24.8% | — |
| VIRP.PA | Virbac | $345.00 +0.44% | $2.89B | 19.4% | 52.4% | — |
| BEAM | Beam Therapeutics | $27.48 +0.84% | $2.84B | 89.8% | 52.4% | — |
| IOVA | Iovance Biotherapeutics | $6.34 +2.09% | $2.83B | 42% | 88.8% | — |
| PRVA | Privia Health Group, Inc. | $22.45 +2.05% | $2.83B | 41.1% | 31.4% | — |
| SUPN | Supernus Pharmaceuticals, Inc. | $47.64 +1.88% | $2.77B | 31.2% | 38% | — |
| ZLAB | Zymeworks | $23.32 +11.69% | $2.62B | 42.4% | 35.4% | — |
| PBH | Prestige Consumer Healthcare In | $54.86 +0.79% | $2.6B | 23.6% | 43% | — |
| NKTR | Nektar Therapeutics | $76.48 +4.13% | $2.58B | 100.3% | 62.6% | — |
| NEOG | Neogen Corporation | $11.47 +1.5% | $2.5B | 13.3% | 82.7% | — |
| TECN.SW | Tecan Group | $195.10 +1.72% | $2.47B | -10.1% | 95.7% | — |
| UFPT | UFP Technologies | $314.01 +0.69% | $2.43B | 13.1% | 95.7% | — |
| XRAY | DENTSPLY SIRONA Inc. | $12.12 -7.97% | $2.43B | 11.1% | 49.7% | — |
| VCEL | Vericel Corporation | $45.09 +0.76% | $2.31B | 34.3% | 79.2% | — |
| HRMY | Harmony Biosciences Holdings, I | $38.41 -0.88% | $2.24B | 20% | 84% | — |
| ADUS | Addus HomeCare Corporation | $119.68 +0.76% | $2.23B | 12.5% | 87% | — |
| ADMA | ADMA Biologics | $9.90 -1.59% | $2.22B | 71.7% | 20.3% | — |
| PGNY | Progyny, Inc. | $28.10 -6.98% | $2.2B | 20.4% | 70.7% | — |
| MD | Pediatrix Medical Group, Inc. | $27.04 +2% | $2.2B | -3.2% | 93.5% | — |
| NEO | NeoGenomics, Inc. | $16.57 +6.49% | $2.16B | 19% | 99.7% | — |
| DRW3.DE | Draegerwerk | $110.20 -0.36% | $2.07B | -4.7% | 93.3% | — |
| SEM | Select Medical Holdings Corpora | $16.51 -0.12% | $2.05B | -0.1% | 91% | — |
| OCUL | Ocular Therapeutix | $9.19 +5.15% | $2.02B | 194.8% | 29% | — |
| DMP.DE | Dermapharm Holding | $40.50 -0.86% | $2.01B | 24.4% | 43.6% | — |
| AGIO | Agios Pharmaceuticals | $32.27 +1% | $1.93B | 41.8% | 42.2% | — |
| NVCR | NovoCure | $16.39 +4.46% | $1.91B | 65.6% | 56.5% | — |
| LMAT | LeMaitre Vascular | $81.45 +0.78% | $1.86B | 40.4% | 5.3% | — |
| CMPS | COMPASS Pathways | $13.54 -0.07% | $1.83B | 77.7% | 83.7% | — |
| DVAX | Dynavax Technologies | $15.50 +0% | $1.82B | 3.2% | 50% | — |
| PRGO | Perrigo Company plc | $12.84 +2.39% | $1.78B | 28.5% | 23.5% | — |
| ANIP | ANI Pharmaceuticals, Inc. | $78.25 -5.3% | $1.78B | 40.6% | 27.6% | — |
| ASTH | Astrana Health Inc. | $35.76 +4.78% | $1.77B | 41.2% | 52.7% | — |
| SRPT | Sarepta Therapeutics | $16.78 +0% | $1.77B | 31.6% | 19.7% | — |
| FTRE | Fortrea Holdings Inc. | $18.43 +4.18% | $1.75B | 11.5% | 80.7% | — |
| INSP | Inspire Medical Systems, Inc. | $60.18 +2.19% | $1.74B | 0.4% | 19.7% | — |
| RXRX | Recursion Pharmaceuticals | $3.22 +1.26% | $1.72B | 125.2% | 10.2% | — |
| BLFS | BioLife Solutions, Inc. | $34.66 +2.15% | $1.69B | -10.2% | 99.4% | — |
| OMCL | Omnicell | $36.81 +1.8% | $1.68B | 57.2% | 29.9% | — |
| ANAB | AnaptysBio | $56.61 +3.36% | $1.68B | 53.8% | 74.2% | — |
| XNCR | Xencor | $20.81 +4.05% | $1.55B | 35.4% | 93.6% | — |
| ENOV | Enovis Corporation | $26.61 +1.12% | $1.53B | 55.4% | 49.3% | — |
| TNDM | Tandem Diabetes Care | $22.38 +19.11% | $1.53B | 26.1% | 63% | — |
| HCSG | Healthcare Services Group, Inc. | $22.23 +0.82% | $1.53B | 20.6% | 70.7% | — |
| PSNL | Personalis | $14.16 +8.67% | $1.51B | -2% | 81.5% | — |
| VIR | Vir Biotechnology, Inc. | $8.82 +0.63% | $1.49B | 139.4% | 62.2% | — |
| INVA | Innoviva | $20.51 -2.84% | $1.48B | 73.1% | 46.2% | — |
| AZTA | Azenta, Inc. | $32.04 +4.23% | $1.48B | 8.6% | 62.4% | — |
| CNMD | Conmed Corporation | $49.06 -1.43% | $1.47B | -7.3% | 69.9% | — |
| ATEC | Alphatec Holdings | $9.31 +1.09% | $1.43B | 70.3% | 15.1% | — |
| FAE.MC | Faes Farma | $4.52 -0.33% | $1.41B | 18.5% | 31.3% | — |
| AMN | AMN Healthcare Services Inc | $35.98 +16.82% | $1.4B | -9.9% | 96.3% | — |
| PAHC | Phibro Animal Health Corporatio | $34.29 -3.41% | $1.39B | 31.2% | 21.4% | — |
| SDGR | Schrodinger | $18.16 +1.97% | $1.36B | 13.3% | 59.8% | — |
| IART | Integra LifeSciences Holdings C | $17.25 +0.88% | $1.34B | 13.4% | 72.5% | — |
| MNKD | MannKind Corporation | $4.11 +5.66% | $1.32B | 96.9% | 43.9% | — |
| AORT | Artivion, Inc. | $27.16 +2.24% | $1.32B | 54.6% | 27.5% | — |
| NVAX | Novavax | $7.95 +2.71% | $1.31B | 77.5% | 30.3% | — |
| CERT | Certara | $8.20 +0.86% | $1.25B | -2% | 39.8% | — |
| USPH | US Physical Therapy | $80.03 +4.67% | $1.22B | 17% | 61.9% | — |
| STAA | STAAR Surgical Company | $24.21 +4.71% | $1.21B | 19.3% | 42.5% | — |
| AVNS | Avanos Medical, Inc. | $24.99 +0.04% | $1.17B | — | 96.9% | — |
| CRVS | Corvus Pharmaceuticals | $13.92 +0.43% | $1.17B | 138.1% | 42.9% | — |
| OPK | OPKO Health | $1.37 +3.79% | $1.02B | 219.3% | 52% | — |
| ARDX | Ardelyx | $4.00 -17.86% | $988.1M | 290% | 1.7% | — |
| PCRX | Pacira BioSciences, Inc. | $25.02 -2.19% | $984.5M | 19.9% | 70.4% | — |
| CBAV.MC | Clinica Baviera | $61.40 +0.99% | $984M | — | 98.2% | — |
| COLL | Collegium Pharmaceutical, Inc. | $29.47 +1.24% | $955.8M | 80.5% | 6.4% | — |
| AMPH | Amphastar Pharmaceuticals, Inc. | $20.78 +4.9% | $916.3M | 5.9% | 28.3% | — |
| INMD | InMode | $15.31 +1.26% | $880M | 0.2% | 64.4% | — |
| EUZ.DE | Eckert and Ziegler | $13.90 +2.21% | $869.8M | 55.4% | 9.9% | — |
| HSTM | HealthStream | $28.72 +2.13% | $839.1M | 20.1% | 87.8% | — |
| QDEL | QuidelOrtho Corporation | $12.29 -24.72% | $837.7M | 73.7% | 9.2% | — |
| AHCO | AdaptHealth Corp. | $5.69 -5.87% | $774.1M | 73.2% | 0.3% | — |
| EVT.DE | Evotec | $3.46 +0.93% | $615.5M | 41.5% | 7% | — |
| LBIRD.PA | Lumibird | $27.00 +1.5% | $595.8M | 19.1% | 88.2% | — |
| CTKB | Cytek Biosciences, Inc. | $4.20 +0.96% | $545.9M | 32.4% | 31.7% | — |
| EOLS | Evolent Health | $7.59 +2.43% | $501.3M | 93.2% | 91.2% | — |
| EDIT | Editas Medicine | $2.88 -0.69% | $442.3M | 108.3% | 42.4% | — |
| WEAV | Weave Communications | $5.29 -20.5% | $421.3M | 60.5% | 27.3% | — |
| CCCC | C4 Therapeutics | $3.73 +2.47% | $412.4M | 257.5% | 58.6% | — |
| REG1V.HE | Revenio Group | $13.56 +4.95% | $394.5M | 42.9% | 12.2% | — |
| PRLD | Prelude Therapeutics | $4.90 +4.7% | $390.3M | 63.3% | 84% | — |
| PACB | Pacific Biosciences | $1.19 +1.72% | $368.1M | 103.9% | 5.8% | — |
| FYB.DE | Formycon | $18.60 -0.43% | $328.7M | 113.3% | 25.1% | — |
| FATE | Fate Therapeutics | $2.80 +12.45% | $326.4M | 93.3% | 81.5% | — |
| TMCI | Treace Medical Concepts | $4.76 +8.68% | $308.8M | -2% | 54.3% | — |
| EMBC | Embecta Corp | $4.42 +26.29% | $262.2M | -9.5% | 12.9% | — |
| SBS.DE | Stratec | $20.40 +2% | $248M | 24.5% | 24.4% | — |
| AMWL | Amwell | $13.44 +3.94% | $224.6M | -11.5% | 93.8% | — |
| RNA | Avidity Biosciences | $12.34 +1.9% | $211.1M | 102.6% | 21.5% | — |
| CRBU | Caribou Biosciences | $1.65 +0.61% | $163.6M | 627.3% | 12.5% | — |
| VXRT | Vaxart | $0.55 -2.68% | $132M | 511.1% | 44.4% | — |
| HCAT | Health Catalyst | $1.73 -25.11% | $127.8M | 33.7% | 27.2% | — |
| SEER | Seer Bio | $2.17 -0.91% | $120M | 84.3% | 72.1% | — |
| HYPR | Hyperfine | $0.95 -2.75% | $94.8M | 126.9% | 7.7% | — |
| NNOX | Nano-X Imaging | $1.06 +3.92% | $73.8M | 384.3% | 7.9% | — |
| TELA | Tela Bio | $0.87 +1.15% | $38.9M | 158.7% | 22.5% | — |
| CTSO | Cytosorbents Corporation | $0.36 -9.68% | $22.6M | 698.6% | 1.1% | — |
| MARI.VI | Marinomed Biotech | $5.40 +8% | $10.8M | — | 17% | — |
Analyse et contexte
Ce filtre sectoriel affiche actuellement 126 actions du segment sélectionné — mis à jour quotidiennement. Le PER moyen est de 34.7x. La croissance moyenne du chiffre d'affaires est de 173.7%. Les secteurs traversent des phases cycliques fortement corrélées aux facteurs macroéconomiques — taux d'intérêt, croissance du PIB, prix des matières premières et environnement réglementaire animent la dynamique sectorielle. Les analystes voient un potentiel moyen de 61.9% sur ces titres. Comparez les ratios à la moyenne du secteur pour identifier les sur- et sous-évaluations relatives. La concentration sectorielle augmente le risque du portefeuille — maintenez une diversification adéquate entre industries et modèles économiques.
Prêt à investir ?
Comparez les meilleurs courtiers pour les actions américaines et européennes — frais, plateformes et types de compte côte à côte.
Comparer les courtiers →